Post-Approval Study of MelaFind

TerminatedOBSERVATIONAL
Enrollment

487

Participants

Timeline

Start Date

November 30, 2012

Primary Completion Date

January 31, 2016

Study Completion Date

January 31, 2016

Conditions
Melanoma
Interventions
DEVICE

MelaFind

The device is used when a dermatologist chooses to obtain additional information on atypical skin lesions for a decision to biopsy.

Trial Locations (6)

21205

The Johns Hopkins University, Baltimore

32308

Dermatology Associates of Tallahassee, Tallahassee

44106

University Hospitals Case Medical Center, Cleveland

80113

AboutSkin Dermatology and DermSurgery, Englewood

02114

Massachusetts General Hospital, Boston

07044

The Dermatology Group, P.C., Verona

Sponsors
All Listed Sponsors
lead

MELA Sciences, Inc.

INDUSTRY